MedicalSystem Biotechnology Co (300439.SZ) Stock Price

MedicalSystem Biotechnology Co Price

SZSE·CLOSED
9.22CNY-0.12 (-1.29 %)
Market closed

Over the last 12 years MedicalSystem Biotechnology Co grew revenue by 14.9% annually, reaching 1.74 B CNY. Earnings per share have grown at 0.8% per year over the last 12 years. For MedicalSystem Biotechnology Co, the net margin of 14.8% is up versus 13.0% a few years ago. At today's price the dividend yield works out to roughly 1.45%. The payout ratio is around 20% of earnings. The dividend has grown at 3.7% per year over the past 8 years. The stock trades about 15% above its 52-week low.

MedicalSystem Biotechnology Co stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of MedicalSystem Biotechnology Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how MedicalSystem Biotechnology Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing MedicalSystem Biotechnology Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

MedicalSystem Biotechnology Co Stock Price History
DateMedicalSystem Biotechnology Co Price
8/24/20269.22 CNY
8/21/20269.34 CNY
8/20/20269.59 CNY
8/19/20269.20 CNY
8/18/20269.41 CNY
8/17/20269.36 CNY
8/14/20269.42 CNY
8/13/20269.27 CNY
8/12/20269.12 CNY
8/11/20269.11 CNY
8/10/20269.24 CNY
8/7/20269.25 CNY
8/6/20268.69 CNY
8/5/20268.70 CNY
8/4/20268.83 CNY
8/3/20268.78 CNY
7/31/20268.64 CNY
7/30/20268.50 CNY
7/29/20268.44 CNY
7/28/20268.39 CNY
7/27/20268.34 CNY
7/24/20268.10 CNY
7/23/20268.37 CNY
7/22/20268.22 CNY
7/21/20268.35 CNY
7/20/20268.55 CNY
7/17/20268.70 CNY
7/16/20269.01 CNY
7/15/20268.92 CNY
7/14/20268.77 CNY
7/13/20268.58 CNY
7/10/20268.46 CNY
7/9/20268.31 CNY
7/8/20268.47 CNY
7/7/20268.48 CNY
7/6/20268.63 CNY
7/3/20268.53 CNY
7/2/20268.35 CNY
7/1/20268.35 CNY
6/30/20268.03 CNY
6/29/20268.29 CNY
6/26/20268.01 CNY
6/25/20268.19 CNY
6/24/20268.38 CNY
6/23/20268.57 CNY
6/22/20268.10 CNY
6/18/20268.38 CNY
6/17/20268.37 CNY
6/16/20268.53 CNY
6/15/20268.59 CNY
6/12/20268.69 CNY
6/11/20268.51 CNY
6/10/20268.66 CNY
6/9/20268.62 CNY
6/8/20268.70 CNY
6/5/20268.91 CNY
6/4/20268.81 CNY
6/3/20269.01 CNY
6/2/20269.15 CNY
6/1/20269.29 CNY
5/29/20269.15 CNY
5/28/20269.05 CNY
5/27/20269.03 CNY
5/26/20269.20 CNY
5/25/20269.40 CNY
5/22/20269.44 CNY
5/21/20269.47 CNY
5/20/20269.84 CNY
5/19/202610.03 CNY
5/18/20269.97 CNY
5/15/202610.01 CNY
5/14/202610.05 CNY
5/13/202610.24 CNY
5/12/202610.29 CNY
5/11/202610.60 CNY
5/8/202610.33 CNY
5/7/202610.19 CNY
5/6/202610.19 CNY
4/30/202610.09 CNY
4/29/202610.09 CNY
4/28/20269.66 CNY
4/27/20269.74 CNY
4/24/20269.70 CNY
4/23/20269.64 CNY
4/22/20269.77 CNY
4/21/20269.78 CNY
4/20/20269.89 CNY
4/17/20269.90 CNY
4/16/20269.95 CNY
4/15/202610.00 CNY
4/14/202610.20 CNY
4/13/20269.75 CNY
4/10/20269.84 CNY
4/9/20269.75 CNY
4/8/20269.95 CNY
4/7/20269.85 CNY
4/3/20269.53 CNY
4/2/20269.97 CNY
4/1/20269.95 CNY
3/31/20269.65 CNY
3/30/20269.74 CNY
3/27/20269.70 CNY
3/26/20269.42 CNY
3/25/20269.56 CNY
3/24/20269.53 CNY
3/23/20269.20 CNY
3/20/20269.88 CNY
3/19/202610.32 CNY
3/18/202610.54 CNY
3/17/202610.25 CNY
3/16/202610.33 CNY
3/13/202610.20 CNY
3/12/202610.14 CNY
3/11/202610.24 CNY
3/10/202610.34 CNY
3/9/202610.18 CNY
3/6/202610.21 CNY
3/5/20269.97 CNY
2/26/202610.31 CNY
2/25/202610.35 CNY
2/24/202610.25 CNY
2/13/202610.15 CNY
2/12/202610.18 CNY
2/11/202610.28 CNY
2/10/202610.35 CNY
2/9/202610.35 CNY
2/6/202610.26 CNY
2/5/202610.21 CNY
2/4/202610.26 CNY
2/3/202610.15 CNY
2/2/202610.04 CNY
1/30/202610.18 CNY
1/29/202610.28 CNY
1/28/202610.36 CNY
1/27/202610.68 CNY
1/26/202611.00 CNY
1/23/202610.45 CNY
1/21/202610.27 CNY
1/20/202610.25 CNY
1/19/202610.28 CNY
1/15/202610.39 CNY
1/14/202610.55 CNY
1/13/202610.47 CNY
1/12/202610.28 CNY
1/9/202610.19 CNY
1/8/202610.14 CNY
1/7/202610.04 CNY
1/6/202610.10 CNY
1/5/202610.11 CNY
12/31/20259.87 CNY
12/30/20259.87 CNY
12/29/20259.86 CNY
12/26/20259.96 CNY
12/25/202510.02 CNY
12/24/202510.01 CNY
12/23/20259.95 CNY
12/22/202510.00 CNY
12/19/202510.10 CNY
12/18/202510.00 CNY
12/17/20259.83 CNY
12/16/20259.77 CNY
12/15/20259.89 CNY
12/12/20259.89 CNY
12/11/20259.93 CNY
12/10/202510.11 CNY
12/9/202510.21 CNY
12/8/202510.36 CNY
12/5/202510.36 CNY
12/4/202510.33 CNY
12/3/202510.40 CNY
12/2/202510.44 CNY
12/1/202510.53 CNY
11/28/202510.50 CNY
11/27/202510.54 CNY
11/26/202510.46 CNY
11/25/202510.51 CNY
11/24/202510.33 CNY
11/21/202510.15 CNY
11/20/202510.62 CNY
11/19/202510.65 CNY
11/18/202510.81 CNY
11/17/202510.92 CNY
11/14/202511.03 CNY
11/13/202510.92 CNY
11/12/202510.90 CNY
11/11/202510.74 CNY
11/10/202510.68 CNY
11/7/202510.64 CNY
11/6/202510.56 CNY
11/5/202510.57 CNY
11/4/202510.51 CNY
11/3/202510.50 CNY
10/31/202510.43 CNY
10/30/202510.20 CNY
10/29/202510.26 CNY
10/28/202510.52 CNY
10/27/202510.49 CNY
10/24/202510.42 CNY
10/23/202510.49 CNY
10/22/202510.48 CNY
10/21/202510.43 CNY
10/20/202510.39 CNY
10/17/202510.16 CNY
10/16/202510.30 CNY
10/15/202510.37 CNY
10/14/202510.22 CNY
10/13/202510.26 CNY
10/10/202510.35 CNY
10/9/202510.30 CNY
9/30/202510.31 CNY
9/29/202510.30 CNY
9/26/202510.26 CNY
9/25/202510.32 CNY
9/24/202510.43 CNY
9/23/202510.26 CNY
9/22/202510.41 CNY
9/19/202510.45 CNY
9/18/202510.53 CNY
9/17/202510.77 CNY
9/16/202510.82 CNY
9/15/202510.75 CNY
9/12/202510.85 CNY
9/11/202510.90 CNY
9/10/202510.77 CNY
9/9/202510.73 CNY
9/8/202510.91 CNY
9/5/202510.70 CNY
9/4/202510.62 CNY
9/3/202510.60 CNY
9/2/202510.80 CNY
9/1/202511.00 CNY
8/29/202510.94 CNY
8/28/202510.98 CNY
8/27/202511.07 CNY
Access this data via the Eulerpool API
Get Free API Key

MedicalSystem Biotechnology Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2017
2.58 B CNY
413.00 M CNY
229.70 M CNY
Jan 1, 2018
3.14 B CNY
426.50 M CNY
241.20 M CNY
Jan 1, 2019
3.13 B CNY
306.00 M CNY
-559.90 M CNY
Jan 1, 2020
2.30 B CNY
266.50 M CNY
299.50 M CNY
Jan 1, 2021
2.25 B CNY
264.57 M CNY
179.49 M CNY
Jan 1, 2022
2.49 B CNY
251.48 M CNY
198.53 M CNY
Jan 1, 2023
1.89 B CNY
277.47 M CNY
256.55 M CNY
Jan 1, 2024
1.74 B CNY
259.58 M CNY
258.00 M CNY

MedicalSystem Biotechnology Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 26, 2026, 3:07 AM
 
REVENUEB CNY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB CNY
EBITM CNY
EBIT MARGIN%
NET INCOMEM CNY
NET INCOME GROWTH%
DIV.CNY
DIV. GROWTH%
SHARESM
2012201320142015201620172018201920202021202220232024
0.330.430.600.681.062.583.143.132.302.252.491.891.74
–32.1138.1914.4154.47144.9321.32-0.06-26.52-2.2210.57-24.27-7.59
59.0258.1056.1158.7154.0337.9634.9334.3436.7940.1237.6544.2444.14
0.190.250.340.400.570.981.101.080.850.900.940.830.77
109.00128.00170.00173.00201.00413.00426.00306.00266.00264.00251.00277.00259.00
33.3329.6328.4825.3319.0515.9813.599.7711.5611.7310.0814.6914.87
91.00103.00137.00161.00177.00229.00241.00-559.00299.00179.00198.00256.00257.00
–13.1933.0117.529.9429.385.24-331.95-153.49-40.1310.6129.290.39
––––0.200.060.130.15–0.160.100.110.13
–––––-70.00116.6715.38––-37.50–30.00
150.00150.00255.00340.00340.00348.00344.50340.00343.00373.93383.00383.00383.95
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales MedicalSystem Biotechnology Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue MedicalSystem Biotechnology Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare MedicalSystem Biotechnology Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares MedicalSystem Biotechnology Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against MedicalSystem Biotechnology Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

MedicalSystem Biotechnology Co stock margins

The MedicalSystem Biotechnology Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of MedicalSystem Biotechnology Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for MedicalSystem Biotechnology Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2017
38.00 %
15.98 %
8.89 %
Jan 1, 2018
34.93 %
13.60 %
7.69 %
Jan 1, 2019
34.35 %
9.77 %
-17.87 %
Jan 1, 2020
36.80 %
11.58 %
13.01 %
Jan 1, 2021
40.15 %
11.75 %
7.97 %
Jan 1, 2022
37.66 %
10.10 %
7.98 %
Jan 1, 2023
44.24 %
14.71 %
13.60 %
Jan 1, 2024
44.17 %
14.90 %
14.81 %

MedicalSystem Biotechnology Co Stock Revenue, EBIT, Earnings per Share

The MedicalSystem Biotechnology Co earnings per share therefore indicates how much revenue MedicalSystem Biotechnology Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2017
7.43 CNY
1.19 CNY
0.66 CNY
Jan 1, 2018
9.10 CNY
1.24 CNY
0.70 CNY
Jan 1, 2019
9.22 CNY
0.90 CNY
-1.65 CNY
Jan 1, 2020
6.71 CNY
0.78 CNY
0.87 CNY
Jan 1, 2021
6.02 CNY
0.71 CNY
0.48 CNY
Jan 1, 2022
6.50 CNY
0.66 CNY
0.52 CNY
Jan 1, 2023
4.92 CNY
0.72 CNY
0.67 CNY
Jan 1, 2024
4.54 CNY
0.68 CNY
0.67 CNY

MedicalSystem Biotechnology Co business model & stock analysis

MedicalSystem Biotechnology Co Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

MedicalSystem Biotechnology Co historical P/E ratio, EBIT multiple, and P/S ratio

MedicalSystem Biotechnology Co annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

MedicalSystem Biotechnology Co shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2017
348.00 M Stocks
Jan 1, 2018
344.50 M Stocks
Jan 1, 2019
340.00 M Stocks
Jan 1, 2020
343.00 M Stocks
Jan 1, 2021
373.93 M Stocks
Jan 1, 2022
383.00 M Stocks
Jan 1, 2023
383.00 M Stocks
Jan 1, 2024
383.95 M Stocks

MedicalSystem Biotechnology Co stock splits

In MedicalSystem Biotechnology Co's history, there have been no stock splits.

MedicalSystem Biotechnology Co Dividend History

9 years of dividend payments · 3 consecutive increases

YearAnnual DividendYoY ChangePayments
20250.13CNY↑ 0.6%1×
Jun 23, 20250.13CNY↑ 0.6%1/1
20240.13CNY↑ 27.6%1×
20230.11CNY↑ 10.5%1×
20220.10CNY↓ 39.4%1×
20210.16CNY↑ 8.0%1×
20190.15CNY↑ 16.1%1×
20180.13CNY↑ 108.6%1×
20170.06CNY↓ 40.1%1×
20160.10CNY—1×

MedicalSystem Biotechnology Co dividend payout ratio

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2017
9.08 %
Jan 1, 2018
17.86 %
Jan 1, 2019
-8.79 %
Jan 1, 2020
17.98 %
Jan 1, 2021
32.65 %
Jan 1, 2022
18.33 %
Jan 1, 2023
15.68 %
Jan 1, 2024
19.94 %
Price targets and forecasts for MedicalSystem Biotechnology Co are not yet available.

MedicalSystem Biotechnology Co shareholder structure

% Name
28.36247%
Zou (Bingde)
Zou (Bingde)
10.41496%
Ningbo Meikang Shengde Investment Consulting Co., Ltd.
Ningbo Meikang Shengde Investment Consulting Co., Ltd.
4.98763%
Chen (Chaohong)
Chen (Chaohong)
3.25790%
Zou (Jihua)
Zou (Jihua)
0.39562%
Huang (Ying Jie)
Huang (Ying Jie)
0.36270%
Wang (Jinkui)
Wang (Jinkui)

MedicalSystem Biotechnology Co Beneficial Ownership Filings (SEC 13D/G)

Free Float
89.7%
Float Shares
-
Shares Outstanding
-

MedicalSystem Biotechnology Co Executives and Management Board

8 members · avg. age 45 · 25 % women

MS

Mr. Min Shen (42)

Deputy General Manager

596,300.00 CNY

Management

LF

Mr. Liang Fang (43)

Deputy General Manager

554,000.00 CNY
HX

Ms. Huiping Xiong (44)

Chief Financial Officer, Deputy General Manager, Secretary of the Board

500,000.00 CNY

Board of Directors

BZ

Mr. Bingde Zou (52)

Chairman of the Board · since 2011

1.20 M CNY
JZ

Mr. Jihua Zou (44)

General Manager, Director · since 2016

874,200.00 CNY
GH

Mr. Gaipeng Huang (37)

Director

582,800.00 CNY
YT

Mr. Yunpeng Tian (49)

Independent Director

100,000.00 CNY
LX

Ms. Ling Xu (45)

Independent Director

–

Frequently asked questions about MedicalSystem Biotechnology Co

5 analysts currently rate the MedicalSystem Biotechnology Co stock: 4 recommend buying, 1 holding and 0 selling.

MedicalSystem Biotechnology Co Analyst Price Targets 2026

Converted at the current exchange rate, the MedicalSystem Biotechnology Co share trades at 1.17 EUR (9.22 CNY).

No history available for MedicalSystem Biotechnology Co.

The revenue cannot currently be calculated for MedicalSystem Biotechnology Co.

The profit cannot currently be calculated for MedicalSystem Biotechnology Co.

The P/E ratio cannot be calculated for MedicalSystem Biotechnology Co at the moment.

The P/S cannot be calculated for MedicalSystem Biotechnology Co currently.

The Eulerpool Quality Score for MedicalSystem Biotechnology Co is 3/10.

The ISIN of MedicalSystem Biotechnology Co is CNE100001Z25. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of MedicalSystem Biotechnology Co is 300439.SZ. The ticker symbol is used to trade MedicalSystem Biotechnology Co shares on the stock exchange.

Over the past 12 months, MedicalSystem Biotechnology Co paid a dividend of 0.13 CNY . This corresponds to a dividend yield of about 1.45 %. For the coming 12 months, MedicalSystem Biotechnology Co is expected to pay a dividend of 0.13 CNY.

The current dividend yield of MedicalSystem Biotechnology Co is 1.45 %.

MedicalSystem Biotechnology Co pays a dividend, distributed in the months of , , , .

MedicalSystem Biotechnology Co paid dividends every year for the past 5 years.

For the upcoming 12 months, dividends amounting to 0.13 CNY are expected. This corresponds to a dividend yield of 1.45 %.

MedicalSystem Biotechnology Co is assigned to the 'Health' sector.

To receive the latest dividend of MedicalSystem Biotechnology Co from amounting to 0.13 CNY, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, MedicalSystem Biotechnology Co distributed 0.11 CNY as dividends.

The dividends of MedicalSystem Biotechnology Co are distributed in CNY.

All fundamentals and in-depth analysis of MedicalSystem Biotechnology Co

Our stock analysis for MedicalSystem Biotechnology Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MedicalSystem Biotechnology Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

MedicalSystem Biotechnology Co Stock
MedicalSystem Biotechnology Co Revenue→
MedicalSystem Biotechnology Co Stock
MedicalSystem Biotechnology Co Net Income→
MedicalSystem Biotechnology Co Stock
MedicalSystem Biotechnology Co P/E→
MedicalSystem Biotechnology Co Stock
MedicalSystem Biotechnology Co P/S→
MedicalSystem Biotechnology Co Stock
MedicalSystem Biotechnology Co EBIT→
MedicalSystem Biotechnology Co Stock
MedicalSystem Biotechnology Co Dividend→
MedicalSystem Biotechnology Co Stock
MedicalSystem Biotechnology Co Directors Dealings→
MedicalSystem Biotechnology Co Stock
MedicalSystem Biotechnology Co Stocks→
MedicalSystem Biotechnology Co Stock
MedicalSystem Biotechnology Co Market capitalization→
MedicalSystem Biotechnology Co Stock
MedicalSystem Biotechnology Co Debt→
MedicalSystem Biotechnology Co Stock
MedicalSystem Biotechnology Co Liabilities→
MedicalSystem Biotechnology Co Stock
MedicalSystem Biotechnology Co Equity→
MedicalSystem Biotechnology Co Stock
MedicalSystem Biotechnology Co AAQS→
MedicalSystem Biotechnology Co Stock
MedicalSystem Biotechnology Co Employees→
MedicalSystem Biotechnology Co Stock
MedicalSystem Biotechnology Co ROE→
MedicalSystem Biotechnology Co Stock
MedicalSystem Biotechnology Co ROA→
MedicalSystem Biotechnology Co Stock
MedicalSystem Biotechnology Co ROCE→
MedicalSystem Biotechnology Co Stock
MedicalSystem Biotechnology Co News→
MedicalSystem Biotechnology Co Stock
MedicalSystem Biotechnology Co Analyst Price Targets→

Health Stocks

Medicamen BiotechMedicalgorithmicsMedicamen OrganicsMedical MarijuanaMedican EnterprisesMedical International TechnologyMedicare Group QPSCMedical ImagingMedicenna TherapeuticsMedical Developments InternationalMedicine Man TechnologiesMedical Connections HoldingsAll Stocks A–Z →